| Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial (NCT05308979) | University of California, Irvine | 2022-05-01 |
| A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder (NCT05381116) | Avation Medical, Inc. | 2022-04-14 |
| AURA 1: Augmenting Urinary Reflex Activity: Study 1 (NCT05256498) | Amber Therapeutics Ltd | 2022-04-01 |
| Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD) (NCT05368246) | InnoCon Medical | 2022-02-15 |
| Sacral Neuromodulation in Neurogenic Patients (NCT05688644) | Omri Schwarztuch Gildor | 2021-12-19 |
| Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence (NCT05099419) | University of Southern California | 2021-10-28 |
| Effects of Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Adults (NCT05464589) | Dow University of Health Sciences | 2021-08-10 |
| Effects of External Neuromuscular Electrical Stimulation in Women With Urgency Urinary Incontinence (NCT04727983) | Recep Tayyip Erdogan University Training and Research Hospital | 2021-07-01 |
| The Effect of Solifenacin Used for Lower Urinary Tract Symptoms on Sexual Function (NCT05391425) | Istanbul University | 2021-06-03 |
| Direct Full-stage Implantation of Sacral Neuromodulation (NCT03697954) | Loma Linda University | 2021-05-01 |
| A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder (NCT04562090) | Astellas Pharma China, Inc. | 2021-01-06 |
| Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women (NCT04752709) | Elidah, Inc. | 2020-11-19 |
| Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence (NCT04470765) | Exodus Innovations | 2020-09-15 |
| Minimizing Pain During Office Intradetrussor Botox Injection (NCT04270526) | Boston Urogynecology Associates | 2020-08-15 |
| What is the Effect of Prolapse Surgery on Voiding? (NCT04429360) | Universiteit Antwerpen | 2020-06-08 |
| High Intensity Focused Electromagnetic Field Device for Urinary Incontinence (NCT04031014) | Boston Urogynecology Associates | 2020-02-01 |
| Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder (NCT05013593) | Regionshospital Nordjylland | 2019-07-15 |
| Enhanced Consent and Preparedness for Surgery Trial (NCT03988569) | Loyola University | 2019-07-01 |
| Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder (NCT05463822) | Stanford University | 2019-06-20 |
| Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence (NCT03489265) | University of North Carolina, Chapel Hill | 2019-04-01 |
| eCoin for OAB Feasibility Follow-on Study (NCT03655054) | Valencia Technologies Corporation | 2019-03-13 |
| EFFECTIVENESS OF THE NEUROADAPTATIVE FOR URGE INCONTINENCE (NCT04164589) | Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias | 2019-02-20 |
| Group Medical Visits for Latina Women With Urgency Urinary Incontinence (NCT03687164) | University of Southern California | 2018-11-01 |
| Oral vs Intravesical Analgesia for Office Bladder Botox Injections (NCT03755089) | Women and Infants Hospital of Rhode Island | 2018-11-01 |
| Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence (NCT03556891) | Valencia Technologies Corporation | 2018-09-04 |
| Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women (NCT04619238) | Medical University of Lublin | 2017-06-01 |
| Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence (NCT03180372) | Sciton | 2017-05-19 |
| A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder (NCT02922842) | University of Rochester | 2016-07-01 |
| Protect Chronic Tibial Nerve Stimulator (CTNS) System (NCT02781636) | Uro Medical Corporation | 2016-04-01 |
| Treatment of Incontinence Without Memory Problems (NCT02436889) | University of California, San Francisco | 2016-02-01 |
| Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB (NCT02657057) | Instituto Médico Tecnológico SL | 2015-11-01 |
| Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder (NCT03033355) | The Methodist Hospital Research Institute | 2014-02-01 |
| Randomized Trial of Tibial Nerve Stimulation Versus Pelvic Floor Exercises for Treatment of Overactive Bladder (NCT02452593) | Federal University of Rio Grande do Sul | 2014-01-01 |
| Trial of Continuous Versus Cyclic Stimulation in Interstim Therapy (NCT00928499) | University of California, Irvine | 2009-04-01 |
| Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder (NCT00773552) | Stamford Hospital | 2008-11-01 |
| Over Active Bladder Instillation Study - Botox (NCT00667095) | Mayo Clinic | 2008-04-01 |
| A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) (NCT00337558) | Astellas Pharma Inc | 2006-05-01 |
| Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control (NCT00225966) | MedtronicNeuro | 2004-08-01 |
| Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence (NCT01391780) | UPECLIN HC FM Botucatu Unesp | 1997-03-01 |
| A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence. (NCT00269750) | Alza Corporation, DE, USA | 1996-07-01 |